eMJA: In Other Journals, 6 July 2009

Intestinal metaplasia of the oesophagus (Barrett’s oesophagus) is associated with an increased risk of oesophageal adenocarcinoma through the development of epithelial dysplasia. In a randomised controlled trial involving 127 patients, researchers in the United States have found that radiofrequency ablation of dysplastic Barrett’s oesophagus was successful in achieving a high rate of eradication of the abnormality, along with a reduced risk of disease progression. The authors caution that the results must be interpreted in relation to the grade of severity of oesophageal dysplasia, which has varying risk of progression to cancer. They also comment on potential side effects, including oesophageal stricture, and suggest the need for cost–benefit analyses.

NB: If you are registered with the eMJA, your username is the email address you have provided.
If you don't have a login, click here for subscription options. You will be prompted to create an account upon purchase.

AMA members can login using their AMA username and password.
If you don't know your AMA password, please contact the AMA on 02 6270 5400 or membership@ama.com.au, or try to retrieve your password at this address.

Username:
Password:

Password forgotten? Click here What is my username?